JOHN HOPE FRANKLIN CENTER
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.duke.edu
LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-05-19
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 24
- Registration Number
- NCT00003020
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
🇺🇸Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States
Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-05-19
- Last Posted Date
- 2013-06-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 36
- Registration Number
- NCT00002988
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor
- Conditions
- Brain and Central Nervous System TumorsLymphoma
- First Posted Date
- 2004-05-04
- Last Posted Date
- 2015-10-15
- Lead Sponsor
- Duke University
- Target Recruit Count
- 19
- Registration Number
- NCT00006342
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-05-03
- Last Posted Date
- 2014-08-21
- Lead Sponsor
- Duke University
- Registration Number
- NCT00005081
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Biological Therapy in Treating Patients With Metastatic Cancer
- Conditions
- Breast CancerColorectal CancerExtrahepatic Bile Duct CancerGallbladder CancerGastric CancerHead and Neck CancerLiver CancerLung CancerMetastatic CancerOvarian Cancer
- Interventions
- Biological: CEA RNA-pulsed DC cancer vaccine
- First Posted Date
- 2004-04-28
- Last Posted Date
- 2013-02-22
- Lead Sponsor
- Duke University
- Target Recruit Count
- 24
- Registration Number
- NCT00004604
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2004-04-27
- Last Posted Date
- 2014-02-10
- Lead Sponsor
- Duke University
- Target Recruit Count
- 8
- Registration Number
- NCT00003434
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer
- Conditions
- Kidney Cancer
- First Posted Date
- 2004-03-23
- Last Posted Date
- 2013-03-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 15
- Registration Number
- NCT00005816
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Temozolomide in Treating Patients With Anaplastic Oligodendroglioma
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-03-12
- Last Posted Date
- 2013-06-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 60
- Registration Number
- NCT00003465
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart Failure
- Conditions
- DepressionHeart Failure, CongestiveChronic Heart Failure
- Interventions
- Drug: PlaceboDrug: Sertraline
- First Posted Date
- 2004-02-24
- Last Posted Date
- 2013-02-27
- Lead Sponsor
- Duke University
- Target Recruit Count
- 469
- Registration Number
- NCT00078286
- Locations
- 🇺🇸
Duke Medical Center, Durham, North Carolina, United States
Treatment of Obsessive Compulsive Disorder in Children
- Conditions
- Obsessive-Compulsive Disorder
- Interventions
- Drug: Serotonin reuptake inhibitors managementBehavioral: Cognitive behavioral therapy by a psychologistBehavioral: Instructional cognitive behavioral therapy by a psychiatrist
- First Posted Date
- 2003-12-22
- Last Posted Date
- 2014-07-29
- Lead Sponsor
- Duke University
- Target Recruit Count
- 124
- Registration Number
- NCT00074815
- Locations
- 🇺🇸
University of Pennsylvania, The Center for the Treatment and Study of Anxiety, Philadelphia, Pennsylvania, United States
🇺🇸Duke Child and Family Study Center, Durham, North Carolina, United States
🇺🇸Rhode Island Hospital, Providence, Rhode Island, United States